search
Back to results

Comparison of Two Laser Therapy Methods for PDR (PDR)

Primary Purpose

Proiriftrative Diabetic Retinopathy

Status
Unknown status
Phase
Phase 2
Locations
Iran, Islamic Republic of
Study Type
Interventional
Intervention
conventional prp
targeted prp
Sponsored by
Shahid Beheshti University of Medical Sciences
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Proiriftrative Diabetic Retinopathy

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • patients with PDR condidate for photocoagulation teraphy
  • Pupil with dilatasion≥6mm
  • without privious treatment with anti VEGF drugs 3months before study
  • without privious vitroretinal sugery
  • without privoius lasertraphy

Exclusion Criteria:

  • To have NVI cricteria with increase of inraocular pressure
  • to have cataract or vitrus leakage which prevent lasertraphy
  • pupil smaller that 6mm
  • traditional retinal detachment
  • privious treatment with anti VEGF drugs 3months before study
  • privious PRP
  • patient unable to get wide field FAG

Sites / Locations

  • Labbafinejad medical centerRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

conventional prp

targeted PRP

Arm Description

Outcomes

Primary Outcome Measures

no leakage in widefield fluorescin angiography

Secondary Outcome Measures

Full Information

First Posted
November 1, 2010
Last Updated
November 1, 2010
Sponsor
Shahid Beheshti University of Medical Sciences
search

1. Study Identification

Unique Protocol Identification Number
NCT01232179
Brief Title
Comparison of Two Laser Therapy Methods for PDR
Acronym
PDR
Official Title
Comparison Between Result and Side Effects of Treatment of Prolifrative Diabetic Retinopaty by Conventional and Extended Targeted Pan Retinal Photocoagolation
Study Type
Interventional

2. Study Status

Record Verification Date
October 2010
Overall Recruitment Status
Unknown status
Study Start Date
October 2010 (undefined)
Primary Completion Date
April 2011 (Anticipated)
Study Completion Date
May 2011 (Anticipated)

3. Sponsor/Collaborators

Name of the Sponsor
Shahid Beheshti University of Medical Sciences

4. Oversight

5. Study Description

Brief Summary
Proliferative diabetic retinopathy (PDR) is treated with conventional pan retinal photocoagulation (PRP) which can improve the visual prognosis in this complication significantly. However , the treatment may also resulting adverse effects such as blurring of central vision, visual field constriction and disturbance in dark adaptation and contrast vision. Extended targeted retinal coagulation (TRP) to the ischemic areas may cause regression of the neovascularization while minimizing some of the risks and complication associated of treatment of PDR with these two methods.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Proiriftrative Diabetic Retinopathy

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Masking
ParticipantInvestigator
Allocation
Randomized

8. Arms, Groups, and Interventions

Arm Title
conventional prp
Arm Type
Active Comparator
Arm Title
targeted PRP
Arm Type
Active Comparator
Intervention Type
Procedure
Intervention Name(s)
conventional prp
Intervention Description
pan retinal photocoagulation
Intervention Type
Procedure
Intervention Name(s)
targeted prp
Intervention Description
1200-1600 spot in far periphery retin, anterior equator
Primary Outcome Measure Information:
Title
no leakage in widefield fluorescin angiography
Time Frame
3 months after lasertraphy

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: patients with PDR condidate for photocoagulation teraphy Pupil with dilatasion≥6mm without privious treatment with anti VEGF drugs 3months before study without privious vitroretinal sugery without privoius lasertraphy Exclusion Criteria: To have NVI cricteria with increase of inraocular pressure to have cataract or vitrus leakage which prevent lasertraphy pupil smaller that 6mm traditional retinal detachment privious treatment with anti VEGF drugs 3months before study privious PRP patient unable to get wide field FAG
Facility Information:
Facility Name
Labbafinejad medical center
City
Tehran
Country
Iran, Islamic Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Masoud Soheilian, proffesor
Phone
00982122585952
Email
masoud_soheilian@yahoo.com
First Name & Middle Initial & Last Name & Degree
masoud soheilian, proffesor

12. IPD Sharing Statement

Citations:
PubMed Identifier
28168567
Citation
Nikkhah H, Ghazi H, Razzaghi MR, Karimi S, Ramezani A, Soheilian M. Extended targeted retinal photocoagulation versus conventional pan-retinal photocoagulation for proliferative diabetic retinopathy in a randomized clinical trial. Int Ophthalmol. 2018 Feb;38(1):313-321. doi: 10.1007/s10792-017-0469-7. Epub 2017 Feb 6.
Results Reference
derived

Learn more about this trial

Comparison of Two Laser Therapy Methods for PDR

We'll reach out to this number within 24 hrs